There is a vitamin product in the United States that has been proven to be effective in many cases against degenerative diseases. Developed by Dr. Ana Aslan, Director of the Bucharest Institute of Geriatrics in Romania, she says tests showed it helped people with:

...just about all the symptoms of ols age. It is called Gerovital H-3 (GH-3).

Why is it that thousands of Americans have been making an expensive pilgrimage to Romania every year? The answer: GH-3 treatments. Why have many famous people such as the Gabor sisters, Marlene Dietrich, Charlie Chaplin, Lillian Gish, John F. Kennedy, Winston Churchill, Charles de Gaulle, Kirk Douglas, Lena Horne, Dick Clark and many others traveled so far to receive these treatments? The reason is that Dr. Ana Aslan proclaims that GH-3 has been proven to have rejuvenative effects at the cellular level and is effective in the fights against the degenerative diseases of aging of which we are all aware. Her research has been documented for 36 years and shows several thousand case histories of relief from just about every disease associated with aging.

Presently the Romania government dispenses GH-3 regularly to its population that is middle-aged and older. Over 200,000 people have received injections or tablets from the Institute, with less than one in six thousand having any allergic reaction at all. There is no limit on age; the oldest patient came to Dr. Aslan when he was 106. He lived ten years more in a much better condition than when he first came to the Institute as a result of treatment with GH-3. The lifespan of all Romanians has benefited greatly from Dr. Aslan's discovery.

GH-3 has become the subject of increasing medical research and recognition around the world during the last quarter century; and it was the subject of a recent best-selling book, "GH3: Will It Keep You Young Longer?" by Herbert Bailey, which had over one million copies sold in the U.S.A. alone. Numerous clinical studies in the U.S. and elsewhere have established the following beneficial properties of GH-3. (1) GH-3 is a potent anti-depressant and "brain tonic"; most users become significantly more alert and cheerful. (2) GH-3 often arrests such aging symptoms as hair loss, greying, wrinkling, and hardened skin. (3) Users of GH-3 have reported dramatic improvements for a great variety of seemingly unrelated problems. These reports are common enough to merit scientific recognition; but they are variable and unpredictable.

Gerovital H-3 has been called the fountain of youth, the miracle anti-aging vitamin product, the total rejuvenator. It is actually a very simple combination of two B vitamins, PABA (para-amino benzoic acid) and DEAE (diethylaminoethanol) buffered and stabilized with benzoic acid and potassium matabisulfite for more effectiveness in the body. Without the complexing developed by Dr. Aslan's studies, GH-3 is called procaine hydrochloride, a vitaminic substance first synthesized in 1905 from two B vitamins by a German scientist, Dr. Albert Einhorn, who was lookin for a simple, non-addictive local anesthetic. What he created was procaine hydrochloride, today approved by the FDA and used throughout the United States under the trade name of Novacaine.

For years it was used as a simple anesthetic, but soon researchers began to notice other curative powers of this substance. Interest in experimentation ran so high that between 1930 and 1951, over 165 reports were published on the effects of procaine in the treatment of a variety of conditions including arthritis, neuralgia, itching, peptic ulcer, asthma and hypertension. In the late 1940's, three French physicians - Drs. Ghall, Bourdon and Guoil - found that procaine hydrochloride helped to relieve suffering from asthma attacks. Dr. Rene Leriche discovered that procaine injections were helpful in freeing certain forms of arthritis, arteritis and blood clots in the limbs.

Once in the body, procaine breaks down into the two B vitamins, PABA and DEAE. By itself, PABA works mostly in the glands, hair and intestines and aids the body in blood cell formation, protein metabolism and skin functions. Studies have shown that a PABA deficiency can cause constipation, depression, digestive disorders, stress, infertility, fatigue, grey hair, headaches and irritability. Its function is to stimulate the intestinal bacterial system to produce other B vitamins such as folic acid, Vitamin B, and pantothenic acid, as well as Vitamin K. Ingesting PABA alone may not always get results because it is not readily absorbed. When nestled in the procaine hydrochloride molecule, PABA becomes more effective.

The other part of the procaine molecule - DEAE - has been shown to have a definite anti-depressant effect. Double blind studies by Carl Pfeiffer, Head of the Brain Bio Center at Princeton, have shown that DEAE produces mental stimulation, and mild euphoria, with no toxic side effects. DEAE also comprises a part of two body substances most important to the central nervous system: choline and acetylcholine. Both are known to be basic parts of the body's stress reaction system.

The eminent medical researcher, Dr. Ana Aslan, first noticed the rejuvenative effects of procaine in her work at the Institute of Geriatrics in Bucharest, where she was first appointed in 1949. Dr. Aslan was able to duplicate the work of Leriche, and began to study procaine's effect on arthritis. Between 1949 and 1951, Aslan conducted animal studies and found that procaine injections yielded complete cures in 85 percent of the laboratory rats that had artificially induced arthritis. Her first clinical tests produced the same results, but Dr. Aslan noticed other afflictions rapidly improved in her group of patients who could not be helped by traditional methods. There was an improvement in memory, a decrease in morbidity due to Parkinson's disease and an increase in muscular power. The psychological effects were also interesting. Patients seemed to be more involved in life.

Intrigued by these discoveries, Dr. Aslan also began to improve upon the basic procaine hydrochloride substance, buffering and stabilizing it, until she came up with a far superior and much more effective compound.

With the perfected GH-3 product, Dr. Aslan immediately began ambitious experiments involving twenty-five patients in a three year study. That year, 1951, the entire Geriatric Institute was turned over to Dr. Aslan - a great vote of confidence for her research. Three years later, in 1954, she reported her findings in the Journal of the Romanian Academy of Science: Patients showed greater vitality and improvements in specific diseases when treated with GH-3.

In 1956, at the Karlsruhe Therapy Congress meeting in Germany, Dr. Aslan presented the following final reseults: studies with three groups of patients living at the Geriatrics Institute, each group containing thirty to forty patients, and 2,500 out patients showed that they were benefited greatly by the use of GH-3. Dr. Aslan claimed that GH-3 relieved depression, hypertension, arthritis and angina pectoris as well as produced muscular vigor and had a "regenerative effect at the cellular level."

These results were confirmed in several Romanian studies, the largest of which took place in 1970, when Dr. Aslan set up one of the most carefully planned scientific experiments ever. For two years, 15,000 people from the ages of forty to sixty-two were tested at over 144 centers throughtout the country. Although patients had all sorts of jobs, and both the control and treated groups received strict medical attention including vitamin therapy, still the GH-3 treated patients showed a significantly higher degree of improvement.

Alfred Sapse had interned as a young doctor in Romania and had seen some of the seemingly miraculous results Dr. Aslan had with GH-3. Said Sapse of the old people who were treated, "Their ailments were either gone or greatly regressed - at least to the point where they didn't bother these old poeple. I saw these people before and after treatment - and I know what I saw, but it was incredible to me. I never forgot it."

Obsessed with his memories of GH-3, Sapse followed studies of GH-3 and the aging process through the years from his position as assistant professor in the Department of Immunology at UCLA. In the early 70s, a team of researchers at the National Institute of Mental Health came up with some definitive answers as to why depression occurs among the elderly, which interested Sapse. The NIMH team had shown that depression was caused by a buildup of the enzyme monoamine oxidase (MAO) in the brain. This was found to occur around age forty-five and to continue with age. The search was on for a product that could inhibit this buildup without destroying the natural usefulness of MAO in the body.

Sapse built his case on research that went back to 1940 - American studies such as that of Dr. J.F. Philpot, who discovered that procaine was a MAO inhibitor in the test tube. But back then, nobody knew what significance MAO had. As soon as the NIMH studies came out, Philpot's discovery look on added meaning, and his results were soon confirmed in Italy. Sapse took all these clues and worked night after night on a computer to come up with the basis for a full-scale U.S. inquiry into GH-3.

Sapse gathered together some top scientists for a battery of tests on GH-3 that would, he hoped, end in FDA approval of its distribution in the United States. His group acquired exclusive rights for distribution from the Romanian government, received an investigative drug number from the FDA, and then moved into action. Their quest: To prove that GH-3 was a safe and effective anti-depressant for the elderly.

The first study confirmed that GH-3 was indeed a MAO inhibitor. This test also showed, however, that GH-3 is a properly weak and reversible inhibitor that does no permanent damage to the MAO system. No other anti-depressant was found to do this.

Next it was shown that GH-3 gave "prompt and dramatic" improvement in depression and insomnia in patients already under psychiatric care. The patitents were also found to have a general improved sense of well-being as a result of the treatment. In addition, those patients with high cholesterol levels were found to have reduced serum cholesterol after only four weeks of treatment.

Phase two of the exhaustive GH-3 investigation consisted of double-blind studies in which the GH-3 would be tested against a placebo with neither the doctor nor patient knowing which group received the real GH-3 until the end of the experiments. The Kurland and Hayman double-blind report at UCLA confirmed GH-3 to be more effective than a placebo with no side effects in sixty-four older patients with depressive conditions.

In addition to the first study, another test, conducted by Duke University's eminent researcher-psychiatrist William W.K. Zung, was actually a triple-blind test because it included a group that received the drug Imipramine, a known and approved remedy for depression. At the end of this experiment, GH-3 proved to be superior to both the placebo and the Imipramine drug.

The final part of the investigation consisted of GH-3 being tested by twenty to thirty psychiatrists all over the country. This was mainly to confirm the efficacy of GH-3 on a larger scale and determine if there was any allergic response.

After three years of study, the incredibly sound and positive case for GH-3 had been made. Sapse was confident that GH-3 would soon pass FDA approval as an effective and safe anti-depressant in geriatric cases - among other important uses - and would soon be able to alleviate the suffering and depression of people in the U.S.

Ironically, it is in the place where the best and most illuminating research was conducted - America - that the mire of politics and confusion would overcome the use of GH-3, and make it impossible for further research to be conducted.

With the cooperation of the Romanian government, and a wealth of scientific testing to back him up, Dr. Alfred Sapse was set to market GH-3 as an anti-depressant upon FDA approval.

At the time, however, a tremendous amount of publicity came to bear about GH-3 as an anti-aging substance. Although GH-3 had been tested throughout the world for the safety of its rejuvenative properties, the FDA felt that not enough research had been done in the United States to prove that GH-3 was indeed useful against aging. The FDA therefore demanded that Sapse prove that GH-3 was also effective against aging.

Sapse appealed this decision which would have taken millions of dollars and several more years of research to prove. In 1976, the FDA agreed to the appeal. Wrote Ross S. Laderman, chief of the Advisory Opinions Branch at the Bureau of Drugs Division of the FDA, "This decision was based on our feeling that there was no evidence that Sapse was responsible for the extravagant publicity surrounding Gerovital and it would be unreasonable for the agency to require that the extravagant claims be tested."

However, when Sapse once again tried for approval the FDA stated that Sapse should test the GH-3 with a younger population, as well as geriatrics. With this decision, Sapse could no longer continue financially. Additional studies to fulfill FDA expectations were estimated to cost $2 million to $3 million and eight years more of research.

Is the FDA's refusal to approve the use of GH-3 based on anything more than economical and political wishes? With the success of GH-3 in so many symptoms that afflict a large population of this country, the multi-billion dollar pharmaceuticals industry could be threatened by the existence of this new vitamin product.

The Institute today finds a spry, energetic Dr. Aslan, who is now 89 years young, working 12 hours a day, 6 days per week. Her duties not only include directing the Institute but flying from country to country to attend medical meetings, usually symposia on aging. She could pass for a person 20 years younger and is blessed with a great sense of humor and a love of mankind. She is happiest when she is helping people.

Today a large number of patients at the Institute are out-patients. Children are now brought to the Institute for skin diseases, osteoporosis, bronchial asthma, rheumatism, alopecia (total baldness), vililigo (loss of pigmentation of hair and skin), and other disorders of premature aging. Many people, including a long list of movie stars and other affluent people, travel to Romania to receive GH-3 treatments.

As far as the Romanian government is concerned, there is no debate for the efficacy of GH-3 as an anti-aging substance. It is provided for thousands of middle-aged and elderly citizens by the government. Aslan has hopes for the American government to do the same. As a matter of fact, she believes the United States, with its great technology, will not only confirm what she has done for the past 36 years, but that it will unravel some of the mysteries of how GH-3 works to the satisfaction and acceptance of all.

Aslan believes that there is no reason why a man cannot live to be 150 years old in full vigor. She believes GH-3 is a good beginning to aging, but it is not the end. Aslan is quick to mention that when talking about GH-3, there is no complete success. "Eventually we all die. But with GH-3 we can die healthier. Aging is like a disease; sometimes you can heal it. Life can be prolonged and, more importantly, these years can be filled with vitality and the joy of life."

Let it be noted here that Dr. Aslan receives no compensation for her work with GH-3. She lives in a socialist country. Her zeal for the promotion and acceptance of GH-3 is strictly a humanitarian venture. Her devotion is to help the debilitated, the senile, and the misfortunate victims of aging. Many people have mentioned that Ana Aslan should be recommended the Nobel Peace Award. This would seem improbable since a woman has not received the award since Madame Curie.

GH-3 is now available in the United States and Canada. You no longer have to travel to Romania for it. Contact TMI at gh3life@earthlink.net to order.